2019
DOI: 10.3390/jfb10030034
|View full text |Cite
|
Sign up to set email alerts
|

Stimuli-Responsive Drug Release from Smart Polymers

Abstract: Over the past 10 years, stimuli-responsive polymeric biomaterials have emerged as effective systems for the delivery of therapeutics. Persistent with ongoing efforts to minimize adverse effects, stimuli-responsive biomaterials are designed to release in response to either chemical, physical, or biological triggers. The stimuli-responsiveness of smart biomaterials may improve spatiotemporal specificity of release. The material design may be used to tailor smart polymers to release a drug when particular stimuli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
90
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 197 publications
(99 citation statements)
references
References 99 publications
0
90
0
Order By: Relevance
“…These functions are often associated with the activation of growth of the bone tissue, cartilage, ligaments, skin, blood vessels, nerves, and muscles [1]. Spongy materials are also used as the carriers for the controlled drugs release [2]. Due to the origin of the raw material, spongy materials are divided into synthetic, natural, and ceramic materials and their combinations.…”
Section: Introductionmentioning
confidence: 99%
“…These functions are often associated with the activation of growth of the bone tissue, cartilage, ligaments, skin, blood vessels, nerves, and muscles [1]. Spongy materials are also used as the carriers for the controlled drugs release [2]. Due to the origin of the raw material, spongy materials are divided into synthetic, natural, and ceramic materials and their combinations.…”
Section: Introductionmentioning
confidence: 99%
“…Enhanced specific drug release could be achieved through stimuli-responsive NPs sensitive to changes in the tumor microenvironment and the tumor cell, e.g., hypoxia; low intracellular pH or increased concentration of enzyme proteases, peptidases, and glutathione; or physical stimuli such as temperature, acoustics, and light. In addition to passive and active targeting, the development of such stimuli-responsive “smart” nanoparticles may overcome barriers to tumor heterogeneity and provide enhanced and selective uptake and release of chemotherapeutics at the target tumor site [ 73 , 74 , 75 , 76 ].…”
Section: Nanoparticle-mediated Tumor Targetingmentioning
confidence: 99%
“…Therefore, in order to design a nanosystem with the drug-release kinetics desired for the target applications, it is important to understand the drug-releasing mechanisms [14]. In the past few years, the concept of stimuli-responsive drug delivery systems (i.e., temperature-responsive, light-responsive, enzyme-responsive, or pH-responsive systems) has been developed for tailoring the release profiles [7,15].…”
Section: Introductionmentioning
confidence: 99%